ADEPT (4% ICODEXTRIN) ADHESION REDUCTION SOLUTION

Barrier, Absorbable, Adhesion

FDA Premarket Approval P050011

This medical device has supplements. The device description/function or indication may have changed. Be sure to look at the supplements to get an up-to-date information on device changes. The labeling included below is the version at time of approval of the original pma or panel track supplement and may not represent the most recent labeling.

Pre-market Approval Supplement Details

Approval for the adept (4% icodextrin) adhesion reduction solution. The device is indicated for use intraperiotoneally as an adjunct to good surgical technique for the reduction of post-surgical adhesions in patients undergoing gynecological laparoscopic adhesiolysis.

DeviceADEPT (4% ICODEXTRIN) ADHESION REDUCTION SOLUTION
Classification NameBarrier, Absorbable, Adhesion
Generic NameBarrier, Absorbable, Adhesion
ApplicantBAXTER HEALTHCARE CORP.
Date Received2005-03-16
Decision Date2006-07-28
Notice Date2006-08-17
PMAP050011
SupplementS
Product CodeMCN
Docket Number06M-0322
Advisory CommitteeObstetrics/Gynecology
Expedited ReviewNo
Combination Product No
Applicant Address BAXTER HEALTHCARE CORP. 1620 Waukegan Road mcgaw Park, IL 60085
Summary:Summary of Safety and Effectiveness
Labeling: Labeling
Approval Order: Approval Order

Supplemental Filings

Supplement NumberDateSupplement Type
P050011Original Filing
S008 2020-04-13 Real-time Process
S007 2020-04-03 Real-time Process
S006 2017-05-17 Normal 180 Day Track No User Fee
S005 2013-08-02 Real-time Process
S004 2013-06-06 30-day Notice
S003 2012-04-24 Special (immediate Track)
S002 2010-11-03 135 Review Track For 30-day Notice
S001 2008-01-09 30-day Notice

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.